首页> 外文期刊>Diabetes >Mitogen-Activated Protein Kinase Phosphatase 3 (MKP-3)-Deficient Mice Are Resistant to Diet-Induced Obesity
【24h】

Mitogen-Activated Protein Kinase Phosphatase 3 (MKP-3)-Deficient Mice Are Resistant to Diet-Induced Obesity

机译:促分裂原激活的蛋白激酶磷酸酶3(MKP-3)缺陷小鼠对饮食诱发的肥胖具有抗性。

获取原文
获取原文并翻译 | 示例
           

摘要

Mitogen-activated protein kinase phosphatase 3 (MKP-3) is a negative regulator of extracellular signal-related kinase signaling. Our laboratory recently demonstrated that MKP-3 plays an important role in obesity-related hypergly-cemia by promoting hepatic glucose output. This study shows that MKP-3 deficiency attenuates body weight gain induced by a high-fat diet (HFD) and protects mice from developing obesity-related hepatosteatosis. Triglyceride (TG) contents are dramatically decreased in the liver of MKP-3~(~/~) mice fed an HFD compared with wild-type (WT) controls. The absence of MKP-3 also reduces adiposity, possibly by repressing adipocyte differentiation. In addition, MKP-3~(~/~) mice display increased energy expenditure, enhanced peripheral glucose disposal, and improved systemic insulin sensitivity. We performed global phosphoproteomic studies to search for downstream mediators of MKP-3 action in liver lipid metabolism. Our results revealed that MKP-3 deficiency increases the phosphorylation of histone deacetylase (HDAC) 1 on ser-ine 393 by 3.3-fold and HDAC2 on serine 394 by 2.33-fold. Activities of HDAC1 and 2 are increased in the livers of MKP-3~(~/~) mice fed an HFD. Reduction of HDAC1/2 activities is sufficient to restore TG content of MKP-3~(~/~) primary hepatocytes to a level similar to that in WT cells.
机译:丝裂原激活的蛋白激酶磷酸酶3(MKP-3)是细胞外信号相关激酶信号的负调节剂。我们的实验室最近证明,MKP-3通过促进肝脏葡萄糖输出在肥胖相关的高血糖症中发挥重要作用。这项研究表明,MKP-3缺乏症可减轻高脂饮食(HFD)诱导的体重增加,并保护小鼠免于肥胖引起的肝脂肪变性。与野生型(WT)对照相比,饲喂HFD的MKP-3〜(〜/〜)小鼠肝脏中甘油三酸酯(TG)含量显着降低。 MKP-3的缺失也可能通过抑制脂肪细胞的分化而减少肥胖。另外,MKP-3〜(〜/〜)小鼠显示出增加的能量消耗,增强的外周葡萄糖处置和改善的全身胰岛素敏感性。我们进行了全球磷酸化蛋白质组学研究,以寻找MKP-3在肝脂质代谢中作用的下游介质。我们的结果表明,MKP-3缺陷使丝氨酸393上的组蛋白脱乙酰基酶(HDAC)1的磷酸化增加3.3倍,而丝氨酸394上的HDAC2的磷酸化增加2.33倍。用HFD喂养的MKP-3〜(〜/〜)小鼠肝脏中HDAC1和2的活性增加。降低HDAC1 / 2活性足以将MKP-3〜(〜/〜)原代肝细胞的TG含量恢复到与WT细胞相似的水平。

著录项

  • 来源
    《Diabetes》 |2014年第9期|2924-2934|共11页
  • 作者单位

    Hallett Center for Diabetes and Endocrinology, Rhode Island Hospital, Brown University, Warren Alpert Medical School, Providence, RI;

    Hallett Center for Diabetes and Endocrinology, Rhode Island Hospital, Brown University, Warren Alpert Medical School, Providence, RI,School of Pharmaceutical Sciences, Jilin University, Changchun, Jilin Province, China;

    Department of Molecular Pharmacology and Physiology, Brown University, Providence, RI;

    Hallett Center for Diabetes and Endocrinology, Rhode Island Hospital, Brown University, Warren Alpert Medical School, Providence, RI;

    Hallett Center for Diabetes and Endocrinology, Rhode Island Hospital, Brown University, Warren Alpert Medical School, Providence, RI;

    Department of Genetic Medicine, Weill Cornell Medical College, New York, NY;

    Department of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI,Department of Chemistry, Brown University, Providence, RI;

    Hallett Center for Diabetes and Endocrinology, Rhode Island Hospital, Brown University, Warren Alpert Medical School, Providence, RI,Pathobiology Program, Brown University, Providence, RI;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号